Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes
{{output}}
Identifying drugs that reverse disease-associated transcriptomic features has been widely explored for drug repurposing, but its potential for de novo drug discovery remains underexplored. Here, we present gene expression profile predictor on chemical structur... ...
